Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms
- 1 December 1992
- journal article
- clinical trial
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 35 (1-2), 167-175
- https://doi.org/10.1016/0165-2427(92)90129-e
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonyl-methoxyethyl)adenine (PMEA)Antiviral Research, 1991
- Anti‐retrovirus activity of 9‐(2‐phosphonylmethoxyethyl)adenine (pmea) in vivo increases when it is less frequently administeredInternational Journal of Cancer, 1990
- Clinical Pharmacokinetics of ZidovudineClinical Pharmacokinetics, 1989
- Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndromeAntimicrobial Agents and Chemotherapy, 1989
- Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compoundsCollection of Czechoslovak Chemical Communications, 1987